RAPIBLOC

300MG INF PLV SOL 1 II

Contact information about Publicly accessible scientific information service operated by marketing authorisation holder.

Company Amomed Pharma GmbH
E-mail i.kral@amomed.com
Telephone number +420 725 825 504

Back to list